These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.
The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...
A small number of patients using GLP-1 weight loss medications have experienced vision loss, although researchers have not ...
The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...
WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...
While many report positive results after taking the medication, experts warn significant weight loss can negatively impact ...